GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | 8/14/2026 4:13:56 PM | View | Proxy | SEC | Y 2025 | ||||||
| Phio Pharmaceuticals Corp. (PHIO) | 8/6/2026 4:28:16 PM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $14,307,000 | Export Earnings Model | |||
| Phio Pharmaceuticals Corp. (PHIO) | 8/6/2026 4:28:05 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $14,307,000 | |||
| Phio Pharmaceuticals Corp. (PHIO) | 5/7/2026 4:40:10 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $17,412,000 | |||
| Phio Pharmaceuticals Corp. (PHIO) | 5/7/2026 4:19:51 PM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $17,412,000 | Export Earnings Model | |||
| Phio Pharmaceuticals Corp. (PHIO) | 3/5/2026 4:26:41 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $21,487,000 | |||
| Phio Pharmaceuticals Corp. (PHIO) | 3/5/2026 4:11:19 PM | View | Financials | Earnings | SEC | Y 2025 | Assets $21,487,000 | Export Earnings Model | |||
| Phio Pharmaceuticals Corp. (PHIO) | 11/13/2025 4:35:32 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $11,505,000 | |||
| Phio Pharmaceuticals Corp. (PHIO) | 11/13/2025 4:23:05 PM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $11,505,000 | Export Earnings Model | |||
| Phio Pharmaceuticals Corp. (PHIO) | 8/14/2025 4:56:35 PM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $11,301,000 | EPS -$0.45 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 8/14/2025 4:53:19 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $11,301,000 | EPS -$0.45 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 7/30/2025 4:03:50 PM | View | Proxy | SEC | Y 2024 | ||||||
| Phio Pharmaceuticals Corp. (PHIO) | 5/15/2025 4:44:46 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $13,440,000 | EPS -$0.41 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 5/15/2025 4:33:09 PM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $13,440,000 | EPS -$0.41 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 3/31/2025 4:53:11 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $231,000 | Assets $5,738,000 | EPS -$9.08 | |
| Phio Pharmaceuticals Corp. (PHIO) | 3/31/2025 4:20:31 PM | View | Financials | Earnings | SEC | Y 2024 | Assets $5,738,000 | EPS -$0.85 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 11/14/2024 5:01:34 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $5,865,000 | EPS -$1.54 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 11/14/2024 4:49:48 PM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $5,865,000 | EPS -$1.54 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 8/14/2024 5:01:51 PM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $5,296,000 | EPS -$3.62 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 8/14/2024 4:56:19 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $5,296,000 | EPS -$3.62 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 5/9/2024 5:37:47 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $6,853,000 | EPS -$0.47 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 5/9/2024 5:24:11 PM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $6,853,000 | EPS -$0.47 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 5/8/2024 5:03:39 PM | View | Proxy | SEC | Y 2023 | ||||||
| Phio Pharmaceuticals Corp. (PHIO) | 4/2/2024 7:31:08 AM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $6,853,000 | EPS -$0.47 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 4/1/2024 4:47:10 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $9,364,000 | EPS -$5.20 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 11/9/2023 4:47:19 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $9,539,000 | EPS -$1.14 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 11/9/2023 4:42:33 PM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $9,539,000 | EPS -$1.14 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 8/10/2023 4:48:58 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $12,296,000 | EPS -$1.47 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 8/10/2023 4:43:16 PM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $12,296,000 | EPS -$1.47 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 6/9/2023 4:31:08 PM | View | Proxy | SEC | Y 2022 | ||||||
| Phio Pharmaceuticals Corp. (PHIO) | 5/11/2023 5:14:06 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $9,707,000 | EPS -$3.15 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 5/11/2023 5:03:01 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $9,707,000 | EPS -$3.15 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 3/22/2023 5:07:57 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $12,814,000 | EPS -$10.10 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 3/22/2023 5:06:31 PM | View | Financials | Earnings | SEC | Y 2022 | Assets $12,814,000 | EPS -$9.46 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 11/30/2022 4:48:04 PM | View | Proxy | SEC | Y 2021 | ||||||
| Phio Pharmaceuticals Corp. (PHIO) | 11/10/2022 5:19:26 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $15,791,000 | EPS -$0.26 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 11/10/2022 5:06:57 PM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $15,791,000 | EPS -$0.26 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 8/11/2022 5:06:34 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $20,144,000 | EPS -$0.19 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 8/11/2022 5:02:24 PM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $20,144,000 | EPS -$0.19 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 6/30/2022 4:32:17 PM | View | Proxy | SEC | Y 2021 | ||||||
| Phio Pharmaceuticals Corp. (PHIO) | 5/12/2022 5:09:39 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $22,162,000 | EPS -$0.19 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 5/12/2022 5:01:27 PM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $22,162,000 | EPS -$0.19 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 3/22/2022 5:23:50 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $25,170,000 | EPS -$12.43 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 3/22/2022 5:06:56 PM | View | Financials | Earnings | SEC | Y 2021 | Assets $25,170,000 | EPS -$11.65 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 11/10/2021 5:28:29 PM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $27,943,000 | EPS -$0.28 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 11/10/2021 4:46:35 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $27,943,000 | EPS -$0.28 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 8/12/2021 5:25:44 PM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $31,657,000 | EPS -$0.20 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 8/12/2021 5:16:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $31,657,000 | EPS -$0.20 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 5/13/2021 5:12:13 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $33,856,000 | EPS -$0.32 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 5/13/2021 5:10:24 PM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $33,856,000 | EPS -$0.32 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 4/30/2021 5:01:39 PM | View | Proxy | SEC | Y 2020 | ||||||
| Phio Pharmaceuticals Corp. (PHIO) | 3/25/2021 7:42:12 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $15,739,000 | EPS -$1.92 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 3/25/2021 7:16:01 PM | View | Financials | Earnings | SEC | Y 2020 | Assets $15,739,000 | EPS -$0.41 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 11/10/2020 5:13:16 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $18,239,000 | EPS -$0.40 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 11/10/2020 5:02:26 PM | View | Financials | Earnings | SEC | 3Q 2020 | Assets $18,239,000 | EPS -$0.40 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 8/28/2020 5:02:09 PM | View | Proxy | SEC | Y 2019 | ||||||
| Phio Pharmaceuticals Corp. (PHIO) | 8/12/2020 5:15:12 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $20,211,000 | EPS -$0.34 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 8/12/2020 5:06:16 PM | View | Financials | Earnings | SEC | 2Q 2020 | Assets $20,211,000 | EPS -$0.34 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 5/12/2020 4:42:26 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $14,305,000 | EPS -$1.33 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 5/12/2020 4:37:38 PM | View | Financials | Earnings | SEC | 1Q 2020 | Assets $14,305,000 | EPS -$1.33 | Export Earnings Model | ||
| Phio Pharmaceuticals Corp. (PHIO) | 3/26/2020 5:33:00 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $21,000 -84.8% | Assets $8,039,000 | EPS -$19.33 | |
| Phio Pharmaceuticals Corp. (PHIO) | 3/26/2020 5:28:23 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $0 | Assets $8,039,000 | EPS -$4.63 | Export Earnings Model | |
| Phio Pharmaceuticals Corp. (PHIO) | 11/22/2019 5:22:57 PM | View | Proxy | SEC | Y 2018 | ||||||
| Phio Pharmaceuticals Corp. (PHIO) | 11/12/2019 7:48:43 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $10,079,000 | EPS -$4.53 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 11/12/2019 7:46:10 AM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $0 | Assets $10,079,000 | EPS -$4.53 | Export Earnings Model | |
| Phio Pharmaceuticals Corp. (PHIO) | 8/30/2019 5:28:31 PM | View | Proxy | SEC | Y 2018 | ||||||
| Phio Pharmaceuticals Corp. (PHIO) | 8/12/2019 5:26:56 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $12,108,000 | EPS -$4.62 | ||
| Phio Pharmaceuticals Corp. (PHIO) | 8/12/2019 5:11:44 PM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $0 | Assets $12,108,000 | EPS -$4.62 | Export Earnings Model | |
| Phio Pharmaceuticals Corp. (PHIO) | 5/14/2019 5:26:08 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $21,000 -8.7% | Assets $13,678,000 | EPS -$5.71 | |
| Phio Pharmaceuticals Corp. (PHIO) | 5/14/2019 5:21:20 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $21,000 -8.7% | Assets $13,678,000 | EPS -$5.71 | Export Earnings Model | |
| Phio Pharmaceuticals Corp. (PHIO) | 3/27/2019 5:28:16 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $138,000 +820.0% | Assets $15,322,000 | EPS -$57.46 | |
| Phio Pharmaceuticals Corp. (PHIO) | 3/27/2019 5:18:00 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $0 | Assets $15,322,000 | EPS -$55.92 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 11/14/2018 7:15:46 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $57,000 | Assets $3,809,000 | EPS -$0.34 | |
| RXi Pharmaceuticals Corp (PHIO) | 11/14/2018 7:11:54 AM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $57,000 | Assets $3,809,000 | EPS -$0.34 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 8/14/2018 9:36:30 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $58,000 | Assets $6,031,000 | EPS -$0.46 | |
| RXi Pharmaceuticals Corp (PHIO) | 8/14/2018 9:17:41 AM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $58,000 | Assets $6,031,000 | EPS -$0.46 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 5/10/2018 7:18:01 AM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $23,000 | Assets $3,090,000 | EPS -$0.90 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 5/10/2018 7:12:42 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $23,000 | Assets $3,090,000 | EPS -$0.90 | |
| RXi Pharmaceuticals Corp (PHIO) | 4/26/2018 5:00:46 PM | View | Proxy | SEC | Y 2017 | ||||||
| RXi Pharmaceuticals Corp (PHIO) | 3/26/2018 5:02:07 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $15,000 -21.1% | Assets $4,098,000 | EPS -$5.52 | |
| RXi Pharmaceuticals Corp (PHIO) | 3/26/2018 5:02:05 PM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2017 ending: 9/30/2017 | Assets $6,033,000 | EPS -$1.05 | ||
| RXi Pharmaceuticals Corp (PHIO) | 3/26/2018 4:54:05 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $15,000 | Assets $4,098,000 | EPS -$0.81 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 3/26/2018 4:52:03 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2017 ending: 6/30/2017 | Assets $8,391,000 | EPS -$1.12 | ||
| RXi Pharmaceuticals Corp (PHIO) | 3/26/2018 4:52:02 PM | Micro | View | Financials | 10-Q/A | SEC | 1Q 2017 ending: 3/31/2017 | Assets $10,512,000 | EPS -$2.65 | ||
| RXi Pharmaceuticals Corp (PHIO) | 11/8/2017 7:15:51 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $6,033,000 | EPS -$1.05 | ||
| RXi Pharmaceuticals Corp (PHIO) | 11/8/2017 7:11:02 AM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $0 | Assets $6,033,000 | EPS -$1.05 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 8/10/2017 7:15:58 AM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $0 | Assets $8,391,000 | EPS -$1.12 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 8/10/2017 7:13:22 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $8,391,000 | EPS -$1.12 | ||
| RXi Pharmaceuticals Corp (PHIO) | 5/11/2017 7:15:33 AM | View | Financials | Earnings | SEC | 1Q 2017 | Assets $10,512,000 | EPS -$2.65 | Export Earnings Model | ||
| RXi Pharmaceuticals Corp (PHIO) | 5/11/2017 7:15:21 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $10,512,000 | EPS -$2.65 | ||
| RXi Pharmaceuticals Corp (PHIO) | 4/27/2017 4:31:06 PM | View | Proxy | SEC | Y 2016 | ||||||
| RXi Pharmaceuticals Corp (PHIO) | 3/30/2017 7:22:02 AM | View | Financials | Earnings | SEC | Y 2016 | Rev $0 | Assets $13,397,000 | EPS -$6.25 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 3/30/2017 7:01:54 AM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $19,000 -44.1% | Assets $13,397,000 | EPS -$16.41 | |
| RXi Pharmaceuticals Corp (PHIO) | 11/10/2016 7:04:32 AM | View | Financials | Earnings | SEC | 3Q 2016 | Assets $4,901,000 | EPS -$3.36 | Export Earnings Model | ||
| RXi Pharmaceuticals Corp (PHIO) | 11/10/2016 7:01:46 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $4,901,000 | EPS -$3.36 | ||
| RXi Pharmaceuticals Corp (PHIO) | 11/4/2016 4:33:04 PM | View | Proxy | SEC | Y 2015 | ||||||
| RXi Pharmaceuticals Corp (PHIO) | 8/11/2016 7:16:02 AM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $9,000 | Assets $6,521,000 | EPS -$3.38 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 8/11/2016 7:01:44 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $9,000 | Assets $6,521,000 | EPS -$3.38 | |
| RXi Pharmaceuticals Corp (PHIO) | 5/12/2016 7:17:04 AM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $10,000 -70.6% | Assets $8,174,000 | EPS -$3.41 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 5/12/2016 7:01:33 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $10,000 -70.6% | Assets $8,174,000 | EPS -$3.41 | |
| RXi Pharmaceuticals Corp (PHIO) | 3/30/2016 4:11:00 PM | View | Financials | Earnings | SEC | Y 2015 | Rev $0 | Assets $11,159,000 | EPS -$0.34 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 3/30/2016 4:08:28 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $34,000 -52.1% | Assets $11,159,000 | EPS -$2.10 | |
| RXi Pharmaceuticals Corp (PHIO) | 3/7/2016 5:20:13 PM | View | Proxy | SEC | Y 2015 | ||||||
| RXi Pharmaceuticals Corp (PHIO) | 11/12/2015 4:10:01 PM | View | Financials | Earnings | SEC | 3Q 2015 | Assets $12,697,000 | EPS -$0.38 | Export Earnings Model | ||
| RXi Pharmaceuticals Corp (PHIO) | 11/12/2015 4:05:34 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Assets $12,697,000 | EPS -$0.38 | ||
| RXi Pharmaceuticals Corp (PHIO) | 8/12/2015 7:16:00 AM | View | Financials | Earnings | SEC | 2Q 2015 | Assets $14,953,000 | EPS -$0.50 | Export Earnings Model | ||
| RXi Pharmaceuticals Corp (PHIO) | 8/12/2015 7:01:17 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Assets $14,953,000 | EPS -$0.50 | ||
| RXi Pharmaceuticals Corp (PHIO) | 5/13/2015 7:12:05 AM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $34,000 +17.2% | Assets $7,169,000 | EPS -$1.32 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 5/13/2015 7:00:47 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $34,000 +17.2% | Assets $7,169,000 | EPS -$1.32 | |
| RXi Pharmaceuticals Corp (PHIO) | 4/16/2015 4:30:54 PM | View | Proxy | SEC | Y 2014 | ||||||
| RXi Pharmaceuticals Corp (PHIO) | 3/30/2015 7:33:52 AM | View | Financials | Earnings | SEC | Y 2014 | Rev $14,000 -96.7% | Assets $9,189,000 | EPS -$7.21 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 3/30/2015 7:33:52 AM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $71,000 -91.1% | Assets $9,189,000 | EPS -$7.90 | |
| RXi Pharmaceuticals Corp (PHIO) | 11/13/2014 7:21:07 AM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $16,000 -82.6% | Assets $10,901,000 | EPS -$0.17 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 11/13/2014 7:01:54 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $16,000 -82.6% | Assets $10,901,000 | EPS -$0.17 | |
| RXi Pharmaceuticals Corp (PHIO) | 8/14/2014 7:15:35 AM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $12,000 -94.7% | Assets $12,550,000 | EPS -$0.23 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 8/14/2014 7:01:10 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $12,000 -94.7% | Assets $12,550,000 | EPS -$0.23 | |
| RXi Pharmaceuticals Corp (PHIO) | 5/14/2014 7:35:36 AM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $29,000 -72.6% | Assets $12,459,000 | EPS -$0.32 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 5/14/2014 7:03:23 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $29,000 -72.6% | Assets $12,459,000 | EPS -$0.32 | |
| RXi Pharmaceuticals Corp (PHIO) | 4/15/2014 4:34:04 PM | View | Proxy | SEC | Y 2013 | ||||||
| RXi Pharmaceuticals Corp (PHIO) | 3/28/2014 5:00:53 PM | View | Financials | Earnings | SEC | Y 2013 | Rev $428,000 +435.0% | Assets $14,938,000 | EPS -$0.24 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 3/28/2014 4:31:56 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $798,000 +311.3% | Assets $14,938,000 | EPS -$2.88 | |
| RXi Pharmaceuticals Corp (PHIO) | 11/14/2013 7:15:59 AM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $92,000 -19.3% | Assets $16,211,000 | EPS -$0.30 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 11/14/2013 6:51:50 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $92,000 -19.3% | Assets $16,211,000 | EPS -$0.30 | |
| RXi Pharmaceuticals Corp (PHIO) | 8/14/2013 10:04:33 AM | View | Financials | Earnings | SEC | 2Q 2013 | Rev $225,000 | Assets $17,996,000 | EPS -$0.39 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 8/14/2013 8:31:40 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $225,000 | Assets $17,996,000 | EPS -$0.39 | |
| RXi Pharmaceuticals Corp (PHIO) | 5/15/2013 7:31:39 AM | View | Financials | Earnings | SEC | 1Q 2013 | Rev $106,000 | Assets $19,972,000 | EPS -$2.76 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 5/15/2013 7:03:50 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $106,000 | Assets $19,972,000 | EPS -$2.76 | |
| RXi Pharmaceuticals Corp (PHIO) | 4/26/2013 7:08:05 AM | View | Proxy | SEC | Y 2012 | ||||||
| RXi Pharmaceuticals Corp (PHIO) | 3/29/2013 7:32:17 AM | View | Financials | Earnings | SEC | Y 2012 | Rev $80,000 | Assets $5,592,000 | EPS -$0.30 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 3/29/2013 7:02:01 AM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $194,000 | Assets $5,592,000 | EPS -$5.62 | |
| RXi Pharmaceuticals Corp (PHIO) | 11/14/2012 7:15:53 AM | View | Financials | Earnings | SEC | 3Q 2012 | Rev $114,000 | Assets $6,712,000 | EPS -$0.56 | Export Earnings Model | |
| RXi Pharmaceuticals Corp (PHIO) | 11/13/2012 4:06:18 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $114,000 | Assets $6,712,000 | EPS -$0.56 | |
| RXi Pharmaceuticals Corp (PHIO) | 8/14/2012 4:06:50 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | ||||
| RXi Pharmaceuticals Corp (PHIO) | 5/14/2012 5:18:31 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 |